CytomX Therapeutics
CTMX
CTMX
75 hedge funds and large institutions have $53.7M invested in CytomX Therapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 36 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
67% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 36
Holders
75
Holding in Top 10
–
Calls
$104K
Puts
$56K
Top Buyers
| 1 | +$3.9M | |
| 2 | +$1.86M | |
| 3 | +$1.39M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.1M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$505K |
Top Sellers
| 1 | -$3.85M | |
| 2 | -$1.15M | |
| 3 | -$1.02M | |
| 4 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$865K |
| 5 |
Renaissance Technologies
New York
|
-$741K |